ROSOPATAMAB
UNII 2TTE6SSR0J

Substance Identification & Data

This profile provides standardized clinical and technical data for Rosopatamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2TTE6SSR0J.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2260767-49-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

2TTE6SSR0J

CAS Registry Number

2260767-49-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ROSOPATAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C2652

National Cancer Institute reference terminology for clinical and research data.

INN ID

11335

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rosopatamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ROSOPATAMAB

Common Names & Synonyms

HUMANIZED MONOCLONAL ANTIBODY TO PSMA

IMMUNOGLOBULIN G1, ANTI-(HUMAN PROSTATE-SPECIFIC MEMBRANE ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL HUJ591 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HUJ591 .KAPPA.-CHAIN, DIMER

MAB MURINE (IGG2A) ANTI Q04609 (FOLH1_HUMAN) (HUJ591)

MOAB, J591, HUMANIZED, TO PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA)

ROSOPATAMAB [INN]